May 3, 2024
Conversation around patient selection and GLP-1 RAs. The
speakers will explore the effects of GLP-1 RAs and SGLT-2
inhibitors on clinical outcomes and CVD risk factors.
Claim CE Credit at https://bit.ly/4aSgdzz
May 3, 2024
Conversation around patient selection and GLP-1 RAs. The
speakers will explore the effects of GLP-1 RAs and SGLT-2
inhibitors on clinical outcomes and CVD risk factors.
Claim CE Credit at https://bit.ly/4aSgdzz